Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2017 17:47 ET | Source: Theratechnologies inc.

Theratechnologies émet un rappel concernant l'expiration de ses bons de souscription

MONTRÉAL, QUÉBEC--(Marketwired - 3 août 2017) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) a tenu aujourd'hui à rappeler aux détenteurs de bons de...
August 03, 2017 17:46 ET | Source: Theratechnologies Inc.

Theratechnologies Issues Reminder Regarding Warrant Expiry

MONTREAL, QUEBEC--(Marketwired - Aug. 3, 2017) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) today issued a reminder to holders of the Company's warrants issued on August 6, 2015,...
August 02, 2017 19:52 ET | Source: Theratechnologies Inc.

Theratechnologies annonce que la FDA a complété l'inspection pré-licence (pre-license inspection) visant l'usine de fabrication de l'ibalizumab

MONTRÉAL, QUÉBEC--(Marketwired - 2 août 2017) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé aujourd'hui que son partenaire, TaiMed Biologics, Inc....
August 02, 2017 19:51 ET | Source: Theratechnologies Inc.

Theratechnologies Announces Completion of the Pre-License Inspection of the Ibalizumab Manufacturing Facility

MONTREAL, QUEBEC--(Marketwired - Aug. 2, 2017) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that it has been notified by its partner, TaiMed Biologics, Inc....
July 24, 2017 07:30 ET | Source: Theratechnologies inc.

Theratechnologies Annonce de Nouvelles Données concernant l'Antirétroviral sous Etude Ibalizumab et concernant EGRIFTAMD (tésamoréline injectable)

MONTRÉAL, QUÉBEC--(Marketwired - 24 juillet 2017) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé aujourd'hui que les résultats de la...
July 24, 2017 07:30 ET | Source: Theratechnologies Inc.

Theratechnologies Announces New Findings with the Investigational Antiretroviral Ibalizumab and with EGRIFTA® (tesamorelin for injection)

MONTREAL, QUEBEC--(Marketwired - July 24, 2017) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) announced today that results on HIV susceptibility to ibalizumab from the Phase IIb...
July 12, 2017 07:30 ET | Source: Theratechnologies inc.

Theratechnologies annonce ses résultats financiers du deuxième trimestre de 2017

MONTRÉAL, QUÉBEC--(Marketwired - 12 juillet 2017) - Theratechnologies inc. (« Theratechnologies ») (TSX:TH) a annoncé aujourd'hui ses résultats financiers...
July 12, 2017 07:30 ET | Source: Theratechnologies Inc.

Theratechnologies Announces Financial Results for Second Quarter of 2017

MONTREAL, QUEBEC--(Marketwired - July 12, 2017) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced its financial results for the second quarter ended May 31, 2017. ...
July 05, 2017 09:46 ET | Source: Theratechnologies inc.

Theratechnologies annoncera ses résultats du deuxième trimestre de 2017

MONTRÉAL, QUÉBEC--(Marketwired - 5 juillet 2017) - Theratechnologies Inc. (TSX:TH) (Theratechnologies) a annoncé aujourd'hui qu'elle dévoilera ses...
July 05, 2017 09:43 ET | Source: Theratechnologies Inc.

Theratechnologies to Announce Financial Results for the Second Quarter of 2017

MONTREAL, QUEBEC--(Marketwired - July 5, 2017) - Theratechnologies Inc. (TSX:TH) (Theratechnologies) announced today that it will issue its financial results for its second...